載入...
A Site-Specifically Labeled Antibody-Drug Conjugate for Simultaneous Therapy and ImmunoPET
The conjugation of antibodies with cytotoxic drugs can alter their in vivo pharmacokinetics. As a result, the careful assessment of the in vivo behavior — and specifically the tumor-targeting properties — of antibody-drug conjugates represents a crucial step in their development. In order to facilit...
Na minha lista:
| 發表在: | Mol Pharm |
|---|---|
| Main Authors: | , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6466629/ https://ncbi.nlm.nih.gov/pubmed/29356543 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acs.molpharmaceut.7b00802 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|